Business Description
Medicure Inc
NAICS : 325412
SIC : 3741
ISIN : CA58469E4085
Compare
Compare
Traded in other countries / regions
MPH.CanadaMCUJF.USANGQ1.Germany IPO Date
2014-02-25Description
Medicure Inc is a biopharmaceutical company. It is involved in the research, clinical development, and commercialization of human therapeutics for the United States hospital market. Further, it also operates a specialty pharmacy in the United States of America. The company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and developing its e-commerce and mail order pharmaceutical business. The company operates in two segments namely, Marketing and distribution of commercial products and, Retail and mail order pharmacy. The majority of the company's revenue is generated from the marketing and distribution of the commercial products segment.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 14.55 | |||||
| Equity-to-Asset | 0.69 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.95 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | -1.85 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 22.4 | |||||
| 3-Year EPS without NRI Growth Rate | 50 | |||||
| 3-Year Book Growth Rate | 0.7 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.11 | |||||
| 9-Day RSI | 45.34 | |||||
| 14-Day RSI | 45.85 | |||||
| 6-1 Month Momentum % | -19.85 | |||||
| 12-1 Month Momentum % | -50 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.87 | |||||
| Quick Ratio | 1.42 | |||||
| Cash Ratio | 0.69 | |||||
| Days Inventory | 151.54 | |||||
| Days Sales Outstanding | 86.36 | |||||
| Days Payable | 329.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.6 | |||||
| Shareholder Yield % | 3.48 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 61.41 | |||||
| Operating Margin % | -12.35 | |||||
| Net Margin % | -12.56 | |||||
| FCF Margin % | 3.46 | |||||
| ROE % | -12.86 | |||||
| ROA % | -9.24 | |||||
| ROIC % | -17.9 | |||||
| 3-Year ROIIC % | -94.98 | |||||
| ROC (Joel Greenblatt) % | -96 | |||||
| ROCE % | -12.62 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 3.39 | |||||
| PS Ratio | 0.47 | |||||
| PB Ratio | 0.53 | |||||
| Price-to-Tangible-Book | 1.33 | |||||
| Price-to-Free-Cash-Flow | 13.38 | |||||
| Price-to-Operating-Cash-Flow | 8.32 | |||||
| EV-to-EBIT | -1.87 | |||||
| EV-to-EBITDA | -11.55 | |||||
| EV-to-Revenue | 0.23 | |||||
| EV-to-FCF | 6.81 | |||||
| Price-to-Median-PS-Value | 0.17 | |||||
| Price-to-Net-Current-Asset-Value | 1.43 | |||||
| Earnings Yield (Greenblatt) % | -53.48 | |||||
| FCF Yield % | 6.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medicure Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 14.301 | ||
| EPS (TTM) (€) | -0.174 | ||
| Beta | 1.21 | ||
| Volatility % | 51.31 | ||
| 14-Day RSI | 45.85 | ||
| 14-Day ATR (€) | 0.054035 | ||
| 20-Day SMA (€) | 0.55425 | ||
| 12-1 Month Momentum % | -50 | ||
| 52-Week Range (€) | 0.486 - 1.07 | ||
| Shares Outstanding (Mil) | 10.44 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medicure Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medicure Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medicure Inc Frequently Asked Questions
What is Medicure Inc(STU:NGQ1)'s stock price today?
The current price of STU:NGQ1 is €0.53. The 52 week high of STU:NGQ1 is €1.07 and 52 week low is €0.49.
When is next earnings date of Medicure Inc(STU:NGQ1)?
The next earnings date of Medicure Inc(STU:NGQ1) is 2024-11-21 Est..
Does Medicure Inc(STU:NGQ1) pay dividends? If so, how much?
Medicure Inc(STU:NGQ1) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers